메뉴 건너뛰기




Volumn 37, Issue 1, 1995, Pages 30-40

Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; METHOTREXATE;

EID: 0028906384     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410370108     Document Type: Article
Times cited : (319)

References (50)
  • 5
    • 0027418515 scopus 로고
    • The IFNB multiple sclerosis study group. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis. 1. Clinical results of a multicenter, randomized, double‐blind, placebocontrolled trial
    • (1993) Neurology , vol.43 , pp. 655-661
  • 6
    • 0020683886 scopus 로고
    • Intensive immunosuppression in progressive multiple sclerosis: a randomized three‐arm study of high dose intravenous cyclophosphamide, plasma exchange, and ACTH
    • (1983) N Engl J Med , vol.308 , pp. 173-180
    • Hauser, SL1    Dawson, DM2    Lehrich, JR3
  • 9
  • 10
  • 14
    • 0025345601 scopus 로고
    • Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double‐blinded, placebo‐controlled clinical trial
    • (1990) Ann Neurol , vol.27 , pp. 591-605
  • 15
    • 0023800068 scopus 로고
    • A closer look at plasmapheresis in multiple sclerosis: the cons
    • (1988) Neurology , vol.38 , pp. 53-56
    • Tindall, R.1
  • 17
    • 0023938566 scopus 로고
    • A long term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty‐three months
    • (1988) Arthritis Rheum , vol.31 , pp. 577-584
    • Kremer, JM1    Lee, JK2
  • 24
  • 27
    • 0021035886 scopus 로고
    • Rating neurologic impairment in multiple sclerosis: an expanded disability scale (EDSS)
    • (1983) Neurology , vol.33 , pp. 1444-1452
    • Kurtzke, JF1
  • 30
    • 84990107526 scopus 로고
    • Low‐dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis: design of a randomized, placebo‐controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicity. Online J Curr Clin Trials [serial online], ; Sep 25 (Doc no. 19)
    • (1992)
    • Goodkin, DE1    Rudick, RA2    Van der Brug Medendorp, S.3
  • 31
    • 0024431267 scopus 로고
    • Rudick RA. Exacerbation rates and adherence to disease type in a prospectively followed‐up population with multiple sclerosis: implications for clinical trials
    • (1989) Arch Neurol , vol.46 , pp. 1107-1112
    • Goodkin, DE1    Hertsgaard, D.2
  • 39
    • 0021666221 scopus 로고
    • Procedures for comparing samples with multiple endpoints
    • (1984) Biometrics , vol.40 , pp. 1079-1087
    • O'Brien, PC1
  • 41
    • 0025075147 scopus 로고
    • Suppresion of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression
    • (1990) Arthritis Rheum , vol.33 , pp. 1156-1161
    • Alarcon, GS1    Schrohenloher, RE2    Bartolucci, AA3
  • 47
    • 0027054129 scopus 로고
    • Possible role of histamine in pathogenesis of autoimmune diseases: implications for immunotherapy with histamine‐2 receptor antagonists
    • (1992) Med Hypotheses , vol.39 , pp. 349-355
    • Nielsen, HJ1    Hammer, JH2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.